Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects
Status:
Completed
Trial end date:
2020-11-20
Target enrollment:
Participant gender:
Summary
SURF-201 is being studied for the treatment of eye inflammation and pain in people who are
undergoing cataract surgery. SURF-201 is an investigational drug (which means the study drug
is currently being tested) in the form of a sterile eye drop.
The purpose of this research study is to see how well SURF-201 works and what side effects
there are, and to compare it with Vehicle (placebo). This study will involve about 80 study
participants at several different research sites in the United States.